Viewing Study NCT01678105

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-04-22 @ 9:08 PM
Study NCT ID: NCT01678105
Status: COMPLETED
Last Update Posted: 2015-09-17
First Post: 2012-08-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands
Sponsor: Ontario Clinical Oncology Group (OCOG)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Adenoid Cystic Carcinoma of the Salivary Glands View
None Metastatic Adenoid Cystic Carcinoma of the Salivary Glands View
None Salivary Gland Cancers View
None ACC View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Recurrent Adenoid Cystic Carcinoma of the Salivary Glands View
None Metastatic Adenoid Cystic Carcinoma of the Salivary Glands View
None Salivary Gland Cancers View
None ACC View
None Dovitinib View
None TKI258 View
None RTK Inhibitor View